Lipoprotein receptors on neovascular endothelial cells — Drug Target

All drugs that target Lipoprotein receptors on neovascular endothelial cells — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Photosensitizing agent

Marketed (3)

• Verteporfin Photodynamic Therapy · Novartis · Photosensitizing agent · Ophthalmology
  Verteporfin is a photosensitizing agent that accumulates in abnormal blood vessels and, when activated by light, generates reactive oxygen species to destroy those vessels.
• Verteporfin for injection · Novartis · Photosensitizing agent · Ophthalmology
  Verteporfin is a photosensitizing agent that accumulates in abnormal blood vessels and, when activated by light, generates reactive oxygen species to destroy those vessels.
• verteporfin PDT · QLT Inc. · Photosensitizing agent · Ophthalmology
  Verteporfin is a photosensitizing agent that accumulates in abnormal blood vessels and is activated by light to generate reactive oxygen species that destroy those vessels.